2016 annual financial data
Ultragenyx Pharmaceutical 2016 Operating cash flow margin
Direct answer
Operating cash flow margin was -121,033.83%.
Operating income was -248,007,000 USD and net income was -245,874,000 USD.
Operating cash flow was -160,975,000 USD.
Get free Ultragenyx Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 133,000 USD
- Operating income
- -248,007,000 USD
- Net income
- -245,874,000 USD
- Operating cash flow
- -160,975,000 USD